Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc.verified

BOLT

Price:

$4.56

Market Cap:

$8.76M

Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies. Its mission is to create agents that equip the body's immune system to identify and eliminate cancerous cells. A key therapeutic in its pipeline is BDC-1001, an investigational treatment targeting the human epidermal growth factor receptor 2 (HER2). This compound is presently undergoing Phase I/II clinical evaluation for patients with HER2-positive solid tumors, including those exhibiting low HER2 expression. Beyond BDC-1001, the company is advancing several other programs: BDC-2034, which targets carcinoembryonic antigen for various indicati...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

BOLT

The Enterprise Value as of June 2026 (TTM) for Bolt Biotherapeutics, Inc. (BOLT) is 19.46M

According to Bolt Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.46M. This represents a change of -4.40% compared to the average of 20.36M of the last 4 quarters.

Bolt Biotherapeutics, Inc. (BOLT) Historical Enterprise Value (quarterly & annually)

How has BOLT Enterprise Value performed in the past?

The mean historical Enterprise Value of Bolt Biotherapeutics, Inc. over the last ten years is 4.45B. The current 19.46M Enterprise Value has changed -56.30% with respect to the historical average. Over the past ten years (40 quarters), BOLT's Enterprise Value was at its highest in in the March 2021 quarter at 22.44B. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

4.45B

Median

1.11B

Minimum

21.48M

Maximum

23.31B

Bolt Biotherapeutics, Inc. (BOLT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bolt Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 354.80%

Maximum Annual Enterprise Value = 23.31B

Minimum Annual Increase = -94.96%

Minimum Annual Enterprise Value = 21.48M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202521.48M-94.96%
2024426.57M-50.19%
2023856.40M-13.03%
2022984.69M-73.11%
20213.66B-84.29%
202023.31B354.80%
20195.13B314.63%

Bolt Biotherapeutics, Inc. (BOLT) Average Enterprise Value

How has BOLT Enterprise Value performed in the past?

The current Enterprise Value of Bolt Biotherapeutics, Inc. (BOLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

434.82M

5-year avg

1.19B

10-year avg

4.45B

Bolt Biotherapeutics, Inc. (BOLT) Enterprise Value vs. Peers

How is BOLT’s Enterprise Value compared to its peers?

Bolt Biotherapeutics, Inc.’s Enterprise Value is greater than Cellectar Biosciences, Inc. (299.98K), greater than Sensei Biotherapeutics, Inc. (-133840780.00), greater than AEON Biopharma, Inc. (5.03M), greater than Cingulate Inc. (8.89M), greater than Imunon, Inc. (1.21M), greater than Lyra Therapeutics, Inc. (15.15M), greater than Marker Therapeutics, Inc. (-14642.00), greater than TransCode Therapeutics, Inc. (-7770350.00), greater than Evogene Ltd. (-1576119.83), greater than IN8bio, Inc. (-12958522.00),

CompanyEnterprise ValueMarket cap
299.98K$7.12M
-133840780.00$17.45M
5.03M$8.64M
8.89M$27.36M
1.21M$5.09M
15.15M$781.13K
-14642.00$14.90M
-7770350.00$5.07M
-1576119.83$5.03M
-12958522.00$6.63M

Build a custom stock screener for Bolt Biotherapeutics, Inc. (BOLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bolt Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bolt Biotherapeutics, Inc. (BOLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bolt Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bolt Biotherapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?

What is the 3-year average Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?

What is the 5-year average Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?

How does the current Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT) compare to its historical average?